| Family Name | Tautomycin |
| Synonyms |
|
| Related Compound Families |
|
| Pathway Type |
PKS - Type I
|
PKS - Type I (Modular)
|
|
| Characteristics |
|
| Pharmacological Identifiers |
Link to PubChem
 | Molecular Mechanisms of Pharmacological Action |
|  | Enzyme Inhibitors |
| Therapeutic Uses |
| | Hematologic Agents |
|
| | Platelet Aggregation Inhibitors |
|
| Image |
|
| Contributor |
Kyle Conway
Boddy Lab
|
| Clusters |
| Accession # | Organism Lineage | Pathway Type | Description | antiSMASH Link | Contributor | Details |
|
EF990140.1
|
Actinobacteria
Actinobacteridae
Actinomycetales
Streptomycineae
Streptomycetaceae
Streptomyces
Actinobacteria
|
PKS - Type I
PKS - Type I (Modular)
|
Streptomyces spiroverticillatus conserved hypothetical protein, hypothetical proteins, putative dehydrogenase, putative MOSC ferredoxin--oxidoreductase, and hypothetical protein genes, complete cds; tautomycin gene cluster, complete sequence; and hypothetical protein genes, complete cds.
|
View
|
Kyle Conway
Boddy Lab
|
|
|